Physician profile
Loan Le
NPI 1720585664
$763.84
in general payments reported to CMS, 2019-2025
6 companies · $24.68 in 2025
The $24.68 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.57 · 2020: $13.86 · 2021: $13.44 · 2022: $123 · 2023: $452 · 2024: $119 · 2025: $24.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $328.93 | 2023 | Xywav |
| Idorsia Pharmaceuticals US INC | $122.91 | 2023 | Quviviq |
| Harmony Biosciences LLC | $122.77 | 2022 | |
| Glaxosmithkline, LLC. | $116.16 | 2024-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $45.87 | 2019-2021 | |
| Viiv Healthcare Company | $27.20 | 2024 | Dovato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loan Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.